- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2018–2023 · cooperative agreement · UH3
A Telehealth Advance Care Planning Intervention for COVID-19 in New York City
James A. Tulsky · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2021 · fellowship · Pew Biomedical Scholars
Pew Biomedical Scholar: Amy S.Y. Lee (2018)
Amy S.Y. Lee · Dana-Farber Cancer Institute · funded by Pew Charitable Trusts
2018–2024 · research · R01
Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation with Movement to Improve Prognosis in Breast Cancer Survivors
Christina Dieli-Conwright · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2019 · fellowship · Banting Postdoctoral Fellowship Program
The context-dependent role of BCOR mutations in Myelodysplastic Syndrome pathogenesis.
Iman Fares · Dana-Farber Cancer Institute · funded by Canadian Institutes of Health Research
2018–2023 · career development · K08
Targeting mitochondrial one carbon folate metabolism for novel T-cell acute lymphoblastic leukemia therapy
Yana Pikman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R01
NMR-based dynamic assessment of TCR transmembrane conformational states linked to T cell function
Ellis L Reinherz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
Donald W. Kufe · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2021 · grant · OCRP
Phase 1 Safety and Feasibility Study of a Personal Neoantigen-Targeting Vaccine in Combination with Immune Checkpoint Blockade in Ovarian Cancer
Panagiotis Konstantinopoulos · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2018–2023 · cooperative agreement · U01
End-of-Life Care for Adolescents and Young Adults with Cancer: An Evaluation of Care and Development of Patient-Centered Quality Measures
Jennifer W Mack · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2020 · research · R01
Ultrabright Theranostic SERRS Nanoparticles for Gastrointestinal Endoscopy
Moritz Florian Kircher · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2020 · career development · K08
Investigating the Mechanisms of Cohesinopathy in Myelodysplastic Syndromes
Zuzana Tothova · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R01
KDM5 histone lysine demethylases as potential novel myeloid tumor suppressors
Julie-Aurore Losman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2019 · career development · K99
Investigating the regulation of mitochondrial heterogeneity and metastasis in melanoma
Chi Luo · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · cooperative agreement · U24
Human Tumor Atlas Network: Data Coordinating Center Supplement
Ethan Cerami · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R37
Targeting blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Andrew A Lane · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
Robert J Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U01
End-of-Life Care for Adolescents and Young Adults with Cancer: An Evaluation of Care and Development of Patient-Centered Quality Measures
Jennifer W Mack · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R01
(PQ5) Contribution of mitochondrial pathways to metabolic heterogeneity in molecular subtypes of Diffuse Large B Cell Lymphoma
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R01
Resistance and Sensitivity to MET Inhibitors in Lung Cancer
Pasi A Janne · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2022 · career development · K01
Selectivity for Kinesin-driven Transport of Axonal RNA Granules
Yusuke Fukuda · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R01
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions
Alexander Gusev · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · research · R01
Immunotherapeutic responses to neoantigens in head and neck cancer
Ravindra Uppaluri · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2021 · research · R03
Preventing Secondary Skin Cancer in Young Adult Cancer Survivors
Christopher John Recklitis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · UM1
SIMPRO Research Center: Integration and Implementation of PROs for Symptom Manage
Michael James Hassett · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · research · R01
Dissecting neoepitope-specific clonal T cell populations in advanced melanoma patients vaccinated with personal neoantigen peptides partnered with local and systemic immune checkpoint Inhibition
Patrick Alexander Ott · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · grant · DP1
Identification of Novel Protein Kinases Dependent on Phosphocreatine Rather than ATP
Bruce M. Spiegelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R01
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions
Alexander Gusev · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · career development · K08
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology
David Liu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · career development · K08
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology
David Liu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2026 · research · R37
Targeting blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Andrew A Lane · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R01
NMR-based dynamic assessment of TCR transmembrane conformational states linked to T cell function
Ellis L Reinherz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R01
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
Eliezer M Van Allen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2019 · research · R01
Molecular mechanisms and therapeutic targeting of PI3K-p110beta/PTEN signaling in breast cancer and cancer immunity
Thomas M Roberts · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R01
NMR-based dynamic assessment of TCR transmembrane conformational states linked to T cell function
Ellis L Reinherz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · research · R01
Tissue-specific genetic interactions in cancer
Kevin Haigis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2022 · research · R01
Advanced computational methods in analyzing high-throughput sequencing data
Heng Li · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
Donald W. Kufe · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2025 · research · R01
Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation with Movement to Improve Prognosis in Breast Cancer Survivors
Christina Dieli-Conwright · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U54
The Center for Synovial Sarcoma Biology and Therapeutics
Cigall Kadoch · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · career development · K07
Obesity and Pancreatic Cancer Progression and Survival
Ana Babic · Dana-Farber Cancer Institute · funded by National Institutes of Health
